Updated: January 27, 2026
Valganciclovir Drug Interactions: What to Avoid and What to Tell Your Doctor
Author
Peter Daggett

Summarize with AI
Valganciclovir has serious drug interactions that can increase blood toxicity or kidney damage. Learn which drugs to avoid and what to tell your doctor before starting.
Valganciclovir (Valcyte) is not taken in isolation. Transplant patients typically take multiple immunosuppressants and other medications simultaneously, and HIV patients on valganciclovir may also be on complex antiretroviral regimens. Understanding which drugs interact dangerously with valganciclovir — and why — can protect you from preventable harm.
Since valganciclovir is rapidly converted to ganciclovir in the body, all of ganciclovir's drug interactions apply equally to valganciclovir.
Category 1: Drugs That Increase Blood Toxicity Risk (Major Interactions)
Valganciclovir suppresses bone marrow — the factory in your body that makes blood cells. When combined with other drugs that do the same, the risk of dangerously low blood counts (neutropenia, anemia, thrombocytopenia) multiplies. The following combinations require careful monitoring or avoidance:
- Zidovudine (AZT, Retrovir): Both drugs cause bone marrow suppression. The combination significantly increases the risk of severe anemia and neutropenia. If both are needed, close blood count monitoring is required and dose adjustments may be necessary. Many HIV specialists try to use alternative antiretrovirals when valganciclovir is needed.
- Mycophenolate mofetil (MMF, CellCept) or mycophenolic acid (Myfortic): These immunosuppressants are taken by almost all transplant patients, including those on valganciclovir. In patients with kidney impairment, both drugs are excreted more slowly, increasing concentrations and toxicity risk for both. Close monitoring of blood counts and renal function is essential.
- Hydroxyurea: Additive bone marrow suppression. Use with caution, monitor blood counts closely.
- Doxorubicin (chemotherapy): Both valganciclovir and doxorubicin cause myelosuppression. Use caution; monitor for additive hematologic toxicity.
- Abacavir (Ziagen): Increased risk of hematologic toxicity. Use alternatives where possible.
Category 2: Drugs That Increase Kidney Damage Risk
Valganciclovir is cleared by the kidneys, and kidney damage slows its elimination, causing drug levels to rise to toxic levels. The following combinations increase risk of acute renal failure:
- Cyclosporine (Neoral, Sandimmune): Nephrotoxic. When combined with valganciclovir, kidney damage risk increases significantly. Monitor kidney function closely.
- Amphotericin B: Antifungal with significant kidney toxicity. The combination with valganciclovir increases renal failure risk.
- NSAIDs (ibuprofen, naproxen, etc.): Common over-the-counter pain relievers can reduce kidney blood flow and increase valganciclovir toxicity. Transplant patients should generally avoid NSAIDs — ask your transplant team before taking any OTC pain medication.
- Trimethoprim (Bactrim/SMX-TMP): Commonly prescribed to transplant patients for PCP pneumonia prevention. Trimethoprim reduces renal tubular secretion of ganciclovir, increasing its blood levels. Monitor kidney function when both are co-prescribed.
Category 3: Drugs That Change Valganciclovir Blood Levels
- Probenecid: Used for gout. Decreases kidney excretion of ganciclovir, raising blood levels and toxicity risk. Monitor for ganciclovir toxicity if probenecid must be co-administered.
- Didanosine (ddI): Ganciclovir can increase didanosine blood levels. Monitor for didanosine toxicity, including pancreatitis. Use alternatives if available.
Category 4: The Imipenem-Cilastatin Warning (Avoid If Possible)
Case reports have documented generalized seizures in patients who received ganciclovir (and by extension valganciclovir) together with imipenem-cilastatin (Primaxin), a carbapenem antibiotic. This combination should be avoided whenever possible. If a carbapenem antibiotic is needed in a patient on valganciclovir, meropenem or ertapenem may be safer alternatives — discuss with your team.
What to Tell Every Doctor, Dentist, and Pharmacist
Whenever you see a new healthcare provider, tell them you are taking valganciclovir. This includes:
- All over-the-counter pain relievers (especially NSAIDs like ibuprofen)
- Vitamins, supplements, and herbal products — some may affect kidney function or blood counts
- Any new antibiotic prescribed — particularly carbapenems or aminoglycosides
- Any changes to your HIV regimen if applicable
For more on the direct side effects of valganciclovir itself, see: Valganciclovir Side Effects: What to Expect and When to Call Your Doctor.
If you are having trouble finding valganciclovir at a pharmacy, medfinder can locate pharmacies near you that can fill it.
Frequently Asked Questions
The most dangerous interactions involve drugs that also suppress bone marrow (zidovudine, hydroxyurea, some chemotherapy agents) and drugs that damage kidneys (cyclosporine, amphotericin B, NSAIDs). The combination with imipenem-cilastatin (an antibiotic) has caused seizures and should be avoided if possible.
Ibuprofen and other NSAIDs (naproxen, aspirin in high doses) can reduce blood flow to the kidneys and increase valganciclovir toxicity. Most transplant physicians recommend avoiding NSAIDs entirely for transplant patients. Use acetaminophen (Tylenol) for pain relief instead, but check with your transplant team first.
Yes. Mycophenolate mofetil (CellCept) and valganciclovir are both commonly taken by transplant patients at the same time. In patients with kidney impairment, both drugs accumulate. The combination requires close monitoring of blood counts and kidney function. Your transplant team is aware of this interaction and will adjust doses as needed.
Some antibiotics interact with valganciclovir. Imipenem-cilastatin (Primaxin) should be avoided due to seizure risk. Trimethoprim (found in Bactrim/SMX-TMP) increases ganciclovir blood levels. Aminoglycoside antibiotics can add to kidney toxicity. Always tell your doctor and pharmacist you are on valganciclovir when any new antibiotic is being considered.
Cyclosporine (Neoral) is nephrotoxic and increases kidney damage risk when combined with valganciclovir. Tacrolimus (Prograf) does not have a well-documented direct pharmacokinetic interaction with valganciclovir, but both are processed by the kidneys, so any reduction in kidney function affects both drugs. Kidney function monitoring is essential for all transplant patients on valganciclovir.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Valganciclovir also looked for:
More about Valganciclovir
31,357 have already found their meds with Medfinder.
Start your search today.





